Amgen Foundation and Changemakers Launch Global Online Competition to Empower Patients

Amgen Inc.The Amgen Foundation is supporting an online competition with Ashoka's Changemakers to find the best solutions that elevate patients' voices to improve health outcomes globally.

The Patients | Choices | Empowerment competition is seeking solutions that tap the medical experience, knowledge, and wisdom of current and past patients, health care practitioners, advocates and other key stakeholders to ensure that patients have an active role in their personal healthcare. The ideal solutions are those that empower the patient and provide avenues for informed decisions.

"With healthcare a key concern around the globe, the Amgen Foundation hopes the competition will surface solutions that can give patients the knowledge and confidence to participate collaboratively at every stage of their healthcare," said Jean J. Lim, president of the Amgen Foundation.

The competition takes place at www.changemakers.com/empower-patient where visitors can enter the competition, discuss and share ideas related to patient empowerment, comment on entries, and vote for the finalists. Finalists will be selected by an expert panel of judges based on innovation, social impact, and sustainability. Three winners will each be awarded US$10,000. Entries will be accepted until Sept. 29, 2010 and the winners will be announced in December 2010.

"We look forward to seeing the global Changemakers community, including Ashoka's network of social entrepreneurs, collaborate to build a worldwide network of support for patients so they experience better health outcomes," said Sushmita Ghosh, founder and chair of Ashoka's Changemakers. "This competition will encourage participants to innovate and collaborate, form partnerships, and build a movement that empowers patients."

Following the Changemakers competition, selected entries may be invited to submit proposals to the Amgen Foundation for future funding consideration. The Amgen Foundation will consider awarding up to US$1 million in grants to support promising innovations in patient empowerment submitted by qualifying nonprofit organizations.

About Ashoka's Changemakers
Ashoka's Changemakers is a community of action that connects social entrepreneurs around the globe to share ideas, inspire, and mentor each other. Through its online collaborative competitions and open-source process, Changemakers.com is one of the world's most robust spaces for launching, discussing, and funding ideas to solve the world's most pressing social problems. Changemakers builds on Ashoka's three decade history and belief that we all have the ability to be a Changemaker.
www.Changemakers.com

About The Amgen Foundation
The Amgen Foundation (http://www.amgen.com/citizenship/overview.html) seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. Since 1991, the Foundation has made more than $140 million in grants to nonprofit organizations throughout the United States, Puerto Rico, and Europe that impact society in inspiring and innovative ways, and those that provide disaster relief efforts both domestically and internationally.

Most Popular Now

Top 20 breaking World Pharma News of 2017

We are proud to announce the top 20 most popular breaking World Pharma News from 2017. Have a wonderful 2018 new(s) year filled with health, happiness, and spectacular su...

Roche and Ignyta reach definitive merger agreement

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Ignyta, Inc. (NASDAQ: RXDX) today announced they have entered into a definitive merger agreement for Roche to fully acquire Ignyta ...

Novartis advances head-to-head superiority trials …

Novartis announced today the initiation of SURPASS, a head-to-head clinical trial of Cosentyx® (secukinumab) versus proposed biosimilar adalimumab** in ankylosing spondyl...

Antidepressant may help combat the course of multi…

The antidepressant clomipramine may also alleviate symptoms of multiple sclerosis (MS), specifically in its progressive form, i.e. when it occurs without relapses or remi...

FDA updates the label of Tasigna to reflect that c…

The U.S. Food and Drug Administration today updated the product label for the cancer drug Tasigna (nilotonib) to include information for providers about how to discontinu...

Distinct human mutations can alter the effect of m…

Every person has a unique DNA sequence in their genome. Now researchers from the University of Copenhagen and the MRC Laboratory of Molecular Biology in Cambridge have tr...

Zika remains a research and public health challeng…

Since 2016, when Zika was declared by the World Health Organization as a public health emergency of international concern, the virus has become established in more than 8...

Diabetes drug 'significantly reverses memory loss…

A drug developed for diabetes could be used to treat Alzheimer's after scientists found it "significantly reversed memory loss" in mice through a triple method of action...

FDA approves novel gene therapy to treat patients …

The U.S. Food and Drug Administration today approved Luxturna (voretigene neparvovec-rzyl), a new gene therapy, to treat children and adult patients with an inherited for...

Try exercise to improve memory, thinking

For patients with mild cognitive impairment, don't be surprised if your health care provider prescribes exercise rather than medication. A new guideline for medical pract...

Arthritis drug could help treat advanced skin canc…

Treatment for the most deadly form of skin cancer could be more effective if combined with a well-known drug for rheumatoid arthritis, new research has shown. The study, ...

Dirt-dwelling microbe produces potential anti-mela…

A type of soil-dwelling bacterium produces molecules that induce death in melanoma cells, research at Oregon State University shows. The molecule is a secondary metabolit...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]